MENACTRA®


Suspension for Injection
scheduling status
S4
registration number
44/30.1/1064
What MENACTRA® contains
Meningococcal (Serogroup A) Polysaccharide (Monovalent Conjugate) 4,0 mcg Meningococcal (Serogroup C) Polysaccharide (Monovalent Conjugate) 4,0 mcg Meningococcal (Serogroup Y) Polysaccharide (Monovalent Conjugate) 4,0 mcg Meningococcal (Serogroup W-135) Polysaccharide (Monovalent Conjugate) 4,0 mcg each of the four polysaccharides is conjugated to diphtheria toxoid : Diphtheria toxoid protein Approximately 48 mcg* *Diphtheria Toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio. There is no latex in any component of the single dose presentation.
other ingredients
Sodium Chloride Dibasic Sodium Phosphate anhydrous Water for injection.
Therapeutic classification
N/A.
© 2026 SAHPRA. ALL RIGHTS RESERVED